| DAA769 |
Reaction time slowing in tasks with conflict between visual stimulus and required motor response |
Psychological |
brain |
Human |
— |
— |
|
| DAA1519 |
receptor accessory protein 6 |
Molecular |
liver |
Mouse |
Reep6 |
5.0% Decrease Gene Expression Level |
|
| DAA960 |
Receptor expression alterations |
Physiological |
grey matter |
Human |
— |
— |
|
| DAA196 |
receptor (G protein-coupled) activity modifying protein 1 |
Molecular |
brain |
Human |
RAMP1 |
16.0% Increase Gene Expression Level |
|
| DAA785 |
Reduced hippocampal activity and functional connectivity in tests for verbal familiarity |
Physiological |
brain |
Human |
— |
— |
|
| DAA2040 |
Reduced type II muscle fiber |
Physiological |
skeletal muscle |
Human |
— |
— |
|
| DAA770 |
Reduction in episodic, working and long-term memory |
Psychological |
brain |
Human |
— |
— |
|
| DAA2020 |
Reduction in renal function |
Physiological |
kidney |
Human |
— |
— |
|
| DAA840 |
Reduction in small intestine absorption rate |
Physiological |
small intestine |
Human |
— |
— |
|
| DAA2049 |
Reduction in total body protein |
Physiological |
whole body |
Human |
— |
— |
|
| DAA206 |
regucalcin (senescence marker protein-30) |
Molecular |
brain |
Human |
RGN |
15.0% Increase Gene Expression Level |
|
| DAA1528 |
regulation of nuclear pre-mRNA domain containing 1B |
Molecular |
liver |
Mouse |
Rprd1b |
10.0% Increase Gene Expression Level |
|
| DAA2015 |
Regulation of the acid-base equilibrium of the blood unchanged |
Physiological |
blood |
Human |
— |
— |
|
| DAA1817 |
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
Molecular |
muscle |
Mouse |
Rcbtb2 |
3.0% Decrease Gene Expression Level |
|
| DAA1687 |
regulator of G-protein signaling 18 |
Molecular |
lung |
Mouse |
Rgs18 |
18.0% Increase Gene Expression Level |
|
| DAA207 |
regulator of G-protein signaling 20 |
Molecular |
brain |
Human |
RGS20 |
25.0% Increase Gene Expression Level |
|
| DAA208 |
regulator of G-protein signaling 4 |
Molecular |
brain |
Human |
RGS4 |
16.0% Decrease Gene Expression Level |
|
| DAA1222 |
RELN promoter methylation increase |
Molecular |
brain, cerebral cortex |
Human |
RELN |
— |
|
| DAA1222 |
RELN promoter methylation increase |
Molecular |
brain, cerebral cortex |
Human |
RELN |
— |
|
| DAA1818 |
RELT-like 1 |
Molecular |
muscle |
Mouse |
Rell1 |
4.0% Increase Gene Expression Level |
|
| DAA886 |
Renal arteriosclerosis |
Pathological |
renal vasculature |
Human |
— |
— |
|
| DAA885 |
Renal blood flow declines |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA640 |
Renal failure |
Pathological |
kidney |
Human |
— |
SeriesMorbidity |
|
| DAA932 |
Renewal capacity declines |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
| DAA2598 |
Renewal rate of cardiomyocytes decreases with age |
Physiological |
heart |
Human |
— |
— |
|